The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection.

Autor: Jacobson JM; Division of Infectious Diseased and HIV Medicine, Drexel University College of Medicine, Philadelphia, PA;†Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA;‡Division of Infectious Diseases, University of Colorado, Denver, CO;§Division of Infectious Diseases, University of Pennsylvania, Philadelphia, PA;‖Profectus BioSciences, Inc., Tarrytown, NY;¶Department of Immunology and Microbiology, Rush University School of Medicine, Chicago, IL;#Department of Neurology, Washington University School of Medicine, St. Louis, MO;**HIV/AIDS Division, University of California, San Francisco, CA;††Social and Scientific Systems, Inc., Silver Springs, MD;‡‡Division of AIDS, NIAID, Bethesda, MD;§§Frontier Science, Amherst, NY; and‖‖Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA., Zheng L, Wilson CC, Tebas P, Matining RM, Egan MA, Eldridge J, Landay AL, Clifford DB, Luetkemeyer AF, Tiu J, Martinez AL, Janik J, Spitz TA, Hural J, McElrath J, Frahm N

Publikováno v: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2016 Feb 01; Vol. 71 (2), pp. 163-71.